VISION PRODUCTS, LLC
Design/develop headlay systems for military /commercial apps
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
MAVEN ADVOCACY PARTNERS LLC | $10,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
MAVEN ADVOCACY PARTNERS LLC | $10,000 reported |
|
1st Quarter - Report 1st Quarter 2026
|
MAVEN ADVOCACY PARTNERS LLC | — reported |
|
1st Quarter - Termination 1st Quarter 2026
|
CASSIDY & ASSOCIATES, INC. | $10,000 reported |
|
Registration 1st Quarter 2026
|
MAVEN ADVOCACY PARTNERS LLC | — reported |
|
4th Quarter - Report 4th Quarter 2025
|
CASSIDY & ASSOCIATES, INC. | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2025
|
CASSIDY & ASSOCIATES, INC. | $30,000 reported |
|
2nd Quarter - Report 2nd Quarter 2025
|
CASSIDY & ASSOCIATES, INC. | $30,000 reported |
|
1st Quarter - Report 1st Quarter 2025
|
CASSIDY & ASSOCIATES, INC. | $30,000 reported |
|
4th Quarter - Report 4th Quarter 2024
|
CASSIDY & ASSOCIATES, INC. | $30,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| CASSIDY & ASSOCIATES, INC. | 17 | $400,000 |
| MAVEN ADVOCACY PARTNERS LLC | 3 | $20,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Defense | DEF | 21 |
| Budget/Appropriations | BUD | 4 |
| Homeland Security | HOM | 3 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.